Krystal Biotech share price logo

Krystal Biotech

NASDAQ: KRYS

Mid Cap

$343.12

+10.30

(+3.09%)

as on

Krystal Biotech Stock Performance

as on August 20, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $335.44
    $345.56
    downward going graph

    2.24%

    Downside

    0.71%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $136.73
    $382.54
    downward going graph

    60.15%

    Downside

    11.49%

    Upside

    downward going graph

Krystal Biotech share price movements today

Previous Close
$332.82
Open
$340.52
Volume
119.3K
Market Cap
$9.8B
Day's Low - High
$335.44 - $345.56
52 Week Low - High
$136.73 - $382.54

Krystal Biotech Historical Returns

1 Month Return
-6.37 %
3 Month Return
+ 8.48 %
1 Year Return
+ 121.12 %
3 Year Return
+ 182.06 %
5 Year Return
+ 488.82 %

Krystal Biotech Stock Fundamentals & Key Indicators

Check Krystal Biotech market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$9.8B

EPS (TTM)

7.8651

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.39%

PE Ratio (TTM)

41.69

Industry PE ratio

-13.046547619047619

PEG Ratio

0

EBITDA

199.3M

Revenue (TTM)

440.5M

Profit Margin

54.82%

Return On Equity TTM

20.12%

Krystal Biotech Stock Valuation

Track how Krystal Biotech P/E has moved over time to understand its valuation trends.

Krystal Biotech in the last 5 years

  • Overview

  • Trends

Lowest (-149.36x)

March 31, 2024

Industry (-13.05x)

August 17, 2026

Today (41.69x)

August 17, 2026

Highest (134.31x)

June 30, 2024

LowHigh

Today’s Price to Earnings Ratio: 41.69x

Krystal Biotech vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Krystal Biotech with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
BUY$9.8B488.82%41.6954.82%NA
BUY$43.7B669.3%NA0.00%NA
BUY$128.2B154.86%29.8286.04%NA
BUY$82.7B24.1%19.2484.86%0.44999999999999996%

Stock Returns calculator for Krystal Biotech Stock including INR - Dollar returns

The Krystal Biotech stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

Krystal Biotech investment value today

Current value as on today

₹2,51,080

Returns

₹1,51,080

(+151.08%)

Returns from Krystal Biotech Stock

₹1,28,336 (+128.34%)

Dollar Impact

₹22,744 (+22.74%)

Analyst Recommendation on Krystal Biotech Stock

Based on 7 analysts

BUY

85.71%

Buy

14.29%

Hold

0.00%

Sell

Based on 7 analysts, 85.71428571428571% of analysts recommend a 'BUY' rating for Krystal Biotech. Average target price of $385

Krystal Biotech Share Price Target

Get share price movements and forecasts by analysts on Krystal Biotech.

What analysts predicted

10.88%UPSIDE

Target Price

$385

Current Price

$343.12

Analyzed by

7 Analysts

Target

$385.00

Krystal Biotech target price $385, a slight upside of 10.88% compared to current price of $343.12. According to 7 analysts rating.

Indian Investors' Interest in Krystal Biotech Stock

Investment in Krystal Biotech Shares on INDmoney has dropped by -7.63% in the last 30 days, indicating reduced investment activity.

Time period: to

Change:-7.63% versus previous 30 day period

Search interest for Krystal Biotech Stock has decreased by -51% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-51% versus previous 30 day period

Krystal Biotech Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
45
70
83
91
88
96
97
107
116
119
Gross Profit
42
64
77
86
83
88
92
96
110
112
Operating Income
-6
8
22
41
36
39
41
44
53
58
EBITDA
7
23
36
50
45
48
49
39
63
66
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
1
2
1
1
1
1
1
1
1
1
Income Before Tax
0
16
29
48
43
46
47
51
61
66
Income Tax Expense
4
0
2
3
7
8
-31
0
5
11
Net Income
0
15
27
45
35
38
79
51
55
54
Net Profit Margin
2.06%
22.15%
32.42%
49.90%
40.52%
39.91%
81.15%
47.99%
48.07%
45.94%

Krystal Biotech Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
1
-
-
-
-
50
290
389
Gross Profit
0
0
0
0
-1
-2
-4
47
270
360
Operating Income
-1
-4
-11
-22
-32
-68
-145
-109
65
161
EBITDA
-1
-4
-10
-18
-30
-66
-116
-91
109
196
Interest Expense
0
3
1
-
0
1
5
-
-
-
Depreciation
-
0
0
0
1
2
4
5
6
6
Income Before Tax
-1
-7
-10
-19
-32
-69
-139
12
95
189
Income Tax Expense
-
-
0
0
1
2
34
1
6
-15
Net Income
-1
-7
-10
-19
-32
-69
-139
10
89
204
Net Profit Margin
0.00%
0.00%
-1060.27%
0.00%
0.00%
0.00%
0.00%
21.56%
30.69%
52.64%

Krystal Biotech Quarterly Cash Flow

All numbers in Millions USD

Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
15
27
45
35
38
79
51
55
54
Operating Cash Flow
-4
58
52
30
52
39
77
80
74
Investing Cash Flow
-19
-34
-83
-54
-10
-4
11
-63
-161
Financing Cash Flow
10
3
2
-12
1
3
15
-10
15
Change in Cash
-13
28
-29
-36
45
38
103
5
-73

Krystal Biotech Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-7
-10
-19
-32
-69
-139
10
89
204
Operating Cash Flow
-3
-9
-18
-26
-47
-100
-88
123
200
Investing Cash Flow
0
-10
-4
-11
-226
-114
82
-163
-58
Financing Cash Flow
51
73
107
118
347
35
202
27
8
Change in Cash
47
54
83
80
72
-179
196
-13
151

Mutual Funds that own Krystal Biotech Stock

Check out the Mutual Funds with significant holdings in Krystal Biotech.

Funds
Holdings
Shares Held
VANGUARD INDEX FUNDS
6.97525%
2064593
Fidelity Select Portfolios
6.103354%
1806522
Fidelity Mt. Vernon Street Trust
4.069541%
1204537
SMALLCAP World Fund Inc
2.541464%
752244
Manager Directed Portfolios
1.114165%
329780

Global Institutional Holdings in Krystal Biotech

Funds
Holdings
Vanguard
8.65%
iShares
7.8%
SPDR
3.04%
Dimensional
0.51%
Michael Rockefeller
0.51%

Insights on Krystal Biotech

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 year, KRYS stock has moved up by 128.2%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Revolution Medicines, Inc. Common Stock has given 629.2% return, outperforming this stock by 450.5%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Revolution Medicines, Inc. Common Stock has given 497.3% return, outperforming this stock by 369.1%

About Krystal Biotech

Krystal Biotech, Inc., a commercial-stage biotechnology company, discovers, develops, manufactures, and commercializes genetic medicines to treat diseases with high unmet medical needs in the United States. The company commercializes VYJUVEK (beremagene geperpavec-svdt, or B-VEC) for the treatment of dystrophic epidermolysis bullosa (DEB). It also develops KB803 for ocular complications of dystrophic epidermolysis bullosa; KB801 for neurotrophic keratitis; KB407, which is in Phase 1 clinical trials for treating cystic fibrosis; KB111 for Hailey-Hailey disease; KB707 for solid tumors; KB304 for dynamic wrinkles; KB707 that is in Phase 1/2 clinical trials for the treatment of anti-PD-1 relapsed/refractory; KB408, which is in Phase 1 clinical trials for treating Alpha-1 antitrypsin deficiency; and KB301 that is in Phase 2 clinical trials for treating aesthetic skin conditions, as well as in open label study with ophthalmic B-VEC for treating for ocular complications of deb. Krystal Biotech, Inc. was founded in 2016 and is headquartered in Pittsburgh, Pennsylvania.
OrganisationKrystal Biotech
Headquarters2100 Wharton Street, Pittsburgh, PA, United States, 15203
IndustryBiotechnology
CEOMr. Krish S. Krishnan M.B.A., M.S.
E-voting on sharesClick here to vote

Key Management of Krystal Biotech

Name

Title

Mr. Krish S. Krishnan M.B.A., M.S.

Founder, Chairman, President & CEO

Ms. Kathryn A. Romano CPA

Executive VP & Chief Accounting Officer

Dr. Stephane Paquette Ph.D.

Senior Vice President of Corporate Development

Mr. Laurent Goux

Executive VP & Head of International

Ms. Christine Wilson

Senior VP & Head of US Commercial

Ms. Suma M. Krishnan

Founder, President of R&D and Director

Mr. John C. Thomas

EVP, General Counsel & Corporate Secretary

Mr. John Karakkal

Vice President of North American Sales & Marketing

Mr. Josh Suskin

Senior Director & Head of US Human Resources

Dr. David Chien M.D.

Senior Vice President of Clinical Development

FAQs

What is Krystal Biotech share price today?

Krystal Biotech share price today is $343.12 as on at the close of the market. Krystal Biotech share today touched a day high of $345.56 and a low of $335.44.

What is the 52 week high and 52 week low for Krystal Biotech share?

Krystal Biotech share touched a 52 week high of $382.54 on and a 52 week low of $136.73 on . Krystal Biotech stock price today i.e. is closed at $343.12,which is 10.30% down from its 52 week high and 150.95% up from its 52 week low.

What is Krystal Biotech's market capitalisation today?

Krystal Biotech market capitalisation is $0.01T as on .

How to invest in Krystal Biotech Stock (KRYS) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Krystal Biotech on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Krystal Biotech Shares that will get you 0.0044 shares as per Krystal Biotech share price of $343.12 per share as on August 20, 2026 at 1:29 am IST.

What is the minimum amount required to buy Krystal Biotech Stock (KRYS) from India?

Indian investors can start investing in Krystal Biotech (KRYS) shares with as little as ₹95.743 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹957.43 in Krystal Biotech stock (as per the Rupee-Dollar exchange rate as on ). Based on Krystal Biotech share’s latest price of $343.12 as on August 20, 2026 at 1:29 am IST, you will get 0.0291 shares of Krystal Biotech. Learn more about fractional shares .

What are the returns that Krystal Biotech has given to Indian investors in the last 5 years?

Krystal Biotech stock has given 488.82% share price returns and 28.54% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?